Amelioration of diabetic neuropathy by TAT-mediated enhanced delivery of metallothionein and SOD

Endocrinology

Volumn 153, Issue 1, 2012, Pages 81-91

  Min, Dongsoo ^a   Kim, Hyunok ^a   Park, Leejin ^a   Kim, Tae Hwa ^a   Hwang, Sejin ^a   Kim, Mi Jung ^a   Jang, Seongho ^a   Park, Yongsoo ^a  

^a Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METALLOTHIONEIN; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL DEATH; CELL STRAIN; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; ELECTROPHYSIOLOGY; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; GLUCOSE INTAKE; HYPOXIA; MALE; MITOCHONDRION; MYELINATION; NERVE CELL; NONHUMAN; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SCIATIC NERVE;

ANIMALS; ANTIOXIDANTS; APOPTOSIS REGULATORY PROTEINS; CELL DEATH; CELL HYPOXIA; DIABETIC NEUROPATHIES; DRUG DELIVERY SYSTEMS; ELECTROPHYSIOLOGICAL PHENOMENA; GLUCOSE; MALE; METALLOTHIONEIN; NEURONS; PC12 CELLS; RATS; RATS, INBRED OLETF; RATS, LONG-EVANS; REACTIVE OXYGEN SPECIES; RECOMBINANT FUSION PROTEINS; SUPEROXIDE DISMUTASE; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSDUCTION, GENETIC;

EID: 84455188695     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1639     Document Type: Article

References (30)

1. Vinik AI, Park TS, Stansberry KB, Pittenger GL 2000 Diabetic neuropathies. Diabetologia 43:957-973 (Pubitemid 30655714)
2. Misur I, Zarković K, Barada A, Batelja L, Milicević Z, Turk Z 2004 Advanced glycation endproducts in peripheral nerve in type 2 diabetes with neuropathy. Acta Diabetol 41:158-166 (Pubitemid 40174991)
3. Vincent AM, Russell JW, Low P, Feldman EL 2004 Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev 25:612-628 (Pubitemid 39096072)
4. Bierhaus A, Haslbeck KM, Humpert PM, Liliensiek B, Dehmer T, Morcos M, Sayed AA, Andrassy M, Schiekofer S, Schneider JG, Schulz JB, Heuss D, Neundörfer B, Dierl S, Huber J, Tritschler H, Schmidt AM, Schwaninger M, Haering HU, Schleicher E, Kasper M, Stern DM, Arnold B, Nawroth PP 2004 Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest 114:1741-1751 (Pubitemid 40385530)
5. Zochodne DW, Cheng C 1999 Diabetic peripheral nerves are susceptible to multifocal ischemic damage from endothelin. Brain Res 838:11-17 (Pubitemid 29389813)
6. Ahlgren SC, Levine JD 1994 Protein kinase C inhibitors decrease hyperalgesia and C-fiber hyperexcitability in the streptozotocin-diabetic rat. J Neurophysiol 72:684-692 (Pubitemid 24273574)
7. Tomlinson DR, Fernyhough P, Diemel LT 1996 Neurotrophins and peripheral neuropathy. Philos Trans R Soc Lond B Biol Sci 351: 455-462 (Pubitemid 126745354)
8. Greene DA, Stevens MJ, Obrosova I, Feldman EL 1999 Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy. Eur J Pharmacol 375:217-223 (Pubitemid 29317606)
9. Rösen P, Nawroth PP, King G, Möller W, Tritschler HJ, Packer L 2001 The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American diabetes association and the German diabetes society. Diabetes Metab Res Rev 17:189-212 (Pubitemid 32624602)
10. Park L, Min D, Kim H, Chung HY, Lee CH, Park IS, Kim Y, Park Y 2011 TAT-enhanced delivery of metallothionein can partially prevent the development of diabetes. Free Radic Biol Med 51:1666-1674
11. Maier CM, Chan PH 2002 Role of superoxide dismutases in oxidative damage and neurodegenerative disorders. Neuroscientist 8:323-334 (Pubitemid 34824016)
12. Vivès E, Brodin P, Lebleu B 1997 A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 272:16010-16017 (Pubitemid 27265584)
13. Kwon HY, Eum WS, Jang HW, Kang JH, Ryu J, Ryong Lee B, Jin LH, Park J, Choi SY 2000 Transduction of Cu,Zn-superoxide dismutase mediated by an HIV-1 Tat protein basic domain into mammalian cells. FEBS Lett 485:163-167
14. Park L, Min D, Kim H, Park J, Choi S, Park Y 2011 The combination of metallothionein and superoxide dismutase protects pancreatic cells from oxidative damage. Diabetes Metab Res Rev 27:802-8
15. Lim M, Park L, Shin G, Hong H, Kang I, Park Y 2008 Induction of apoptosis of β cells of the pancreas by advanced glycation endproducts, important mediators of chronic complications of diabetes mellitus. Ann NY Acad Sci 1150:311-315
16. Russell JWSA, Singleton JR 2006 Impaired glucose regulation and neuropathy. In: Gilman S, ed. Neurobiology of diseases. San Diego: Elsevier; 849-869
17. Patel M 1998 Inhibition of neuronal apoptosis by a metalloporphyrin superoxide dismutase mimic. J Neurochem 71:1068-1074 (Pubitemid 28390260)
18. Nagamatsu M, Nickander KK, Schmelzer JD, Raya A, Wittrock DA, Tritschler H, Low PA 1995 Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 18:1160-1167
19. Stevens MJ, Obrosova I, Cao X, Van Huysen C, Greene DA 2000 Effects of DL-α-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 49:1006-1015 (Pubitemid 30349424)
20. Patel M, Day BJ, Crapo JD, Fridovich I, McNamara JO 1996 Requirement for superoxide in excitotoxic cell death. Neuron 16:345-355 (Pubitemid 26072367)
21. Greenlund LJ, Deckwerth TL, Johnson Jr EM 1995 Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 14:303-315
22. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF 1999 In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285:1569-1572 (Pubitemid 29420581)
23. Grdisa M 2011 The delivery of biologically active (therapeutic) peptides and proteins into cells. Curr Med Chem 18:1373-1379
24. Johnson RM, Harrison SD, Maclean D 2011 Therapeutic applications of cell-penetrating peptides. Methods Mol Biol 683:535-551
25. Takano K, Kitao Y, Tabata Y, Miura H, Sato K, Takuma K, Yamada K, Hibino S, Choshi T, Iinuma M, Suzuki H, Murakami R, Yamada M, Ogawa S, Hori O 2007 A dibenzoylmethane derivative protects dopaminergic neurons against both oxidative stress and endoplasmic reticulum stress. Am J Physiol Cell Physiol 293: C1884-C1894 (Pubitemid 350255085)
26. Bossy-Wetzel E, Schwarzenbacher R, Lipton SA 2004 Molecular pathways to neurodegeneration. Nat Med 10:S2-S9 (Pubitemid 38901861)
27. Kaneto H, Matsuoka TA, Nakatani Y, Kawamori D, Miyatsuka T, Matsuhisa M, Yamasaki Y 2005 Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes. J Mol Med 83:429-439 (Pubitemid 40922165)
28. Hung CC, Ichimura T, Stevens JL, Bonventre JV 2003 Protection of renal epithelial cells against oxidative injury by endoplasmic reticulum stress preconditioning is mediated by ERK1/2 activation. J Biol Chem 278:29317-29326 (Pubitemid 36935848)
29. Nakamura J, Hamada Y, Sakakibara F, Hara T, Wakao T, Mori K, Nakashima E, Naruse K, Kamijo M, Koh N, Hotta N 2001 Physiological and morphometric analyses of neuropathy in sucrose-fed OLETF rats. Diabetes Res Clin Pract 51:9-20 (Pubitemid 32008447)
30. Thomas PK 1999 Diabetic neuropathy: mechanisms and future treatment options. J Neurol Neurosurg Psychiatry 67:277-279 (Pubitemid 29392582)